Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol fast-track anesthesia in congenital heart disease interventional surgery
ChiCTR2500109737Phase 4Completed
- Sponsor
- Fuwai Central China Cardiovascular Hospital
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in Cardiovascular Malformation (CVM) (4 arms), sponsored by Fuwai Central China Cardiovascular Hospital. Primary endpoints: Time to extubation, Time of loss of consciousness and 1 more. Started Sep 2025; status: completed.
02
Drugs
remimazolam
03
Conditions
Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on ChiCTR2500109737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500109737.